Morgan Stanley Issues Positive Forecast for Lemonade (NYSE:LMND) Stock Price

Lemonade (NYSE:LMNDFree Report) had its price objective boosted by Morgan Stanley from $43.00 to $45.00 in a research note published on Tuesday, MarketBeat.com reports. They currently have an underweight rating on the stock.

Several other brokerages have also recently commented on LMND. Cantor Fitzgerald raised shares of Lemonade to a “strong-buy” rating in a research report on Wednesday, August 13th. Keefe, Bruyette & Woods reissued an “underperform” rating and set a $26.00 price target (up from $22.00) on shares of Lemonade in a research report on Tuesday, July 1st. Wall Street Zen raised shares of Lemonade from a “sell” rating to a “hold” rating in a research report on Saturday, August 9th. BMO Capital Markets upped their target price on shares of Lemonade from $23.00 to $42.00 and gave the company an “underperform” rating in a report on Monday, August 18th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Lemonade in a report on Saturday, September 27th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has given a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Reduce” and an average target price of $43.86.

View Our Latest Report on LMND

Lemonade Trading Down 1.9%

LMND opened at $55.03 on Tuesday. The stock has a market capitalization of $4.07 billion, a P/E ratio of -19.45 and a beta of 2.24. Lemonade has a 12 month low of $15.27 and a 12 month high of $62.00. The firm’s fifty day simple moving average is $52.67 and its 200 day simple moving average is $41.07.

Lemonade (NYSE:LMNDGet Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported ($0.60) EPS for the quarter, beating the consensus estimate of ($0.81) by $0.21. Lemonade had a negative net margin of 33.96% and a negative return on equity of 36.12%. The business had revenue of $164.10 million for the quarter, compared to analysts’ expectations of $160.88 million. During the same period in the previous year, the firm posted ($0.81) EPS. The firm’s revenue was up 34.5% compared to the same quarter last year. Lemonade has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, equities research analysts predict that Lemonade will post -3.03 EPS for the current fiscal year.

Insider Transactions at Lemonade

In related news, COO Adina Eckstein sold 5,000 shares of the company’s stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $49.00, for a total value of $245,000.00. Following the transaction, the chief operating officer owned 189,653 shares in the company, valued at approximately $9,292,997. This represents a 2.57% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider John Sheldon Peters sold 2,718 shares of the company’s stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $50.34, for a total transaction of $136,824.12. Following the completion of the transaction, the insider owned 102,397 shares in the company, valued at approximately $5,154,664.98. This trade represents a 2.59% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 8,000 shares of company stock worth $396,020. 12.50% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Mandatum Life Insurance Co Ltd acquired a new position in Lemonade in the 2nd quarter valued at about $202,000. Caxton Associates LLP acquired a new position in Lemonade in the 1st quarter valued at about $1,455,000. Nomura Holdings Inc. acquired a new position in Lemonade in the 1st quarter valued at about $416,000. Dynamic Technology Lab Private Ltd acquired a new position in shares of Lemonade during the 1st quarter worth approximately $638,000. Finally, GAMMA Investing LLC grew its position in shares of Lemonade by 35,901.8% during the 1st quarter. GAMMA Investing LLC now owns 19,801 shares of the company’s stock worth $630,000 after purchasing an additional 19,746 shares in the last quarter. Institutional investors and hedge funds own 80.30% of the company’s stock.

About Lemonade

(Get Free Report)

Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.

See Also

Analyst Recommendations for Lemonade (NYSE:LMND)

Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.